发明名称 Development of Novel Macromolecule Transduction Domain with Improved Cell Permeability and Method for Using Same
摘要 The present invention relates to an improved macromolecule transduction domain (MTD), which facilitates permeating the cell membrane of a biologically active molecule, having enhanced cell permeability. Specifically, an improved MTD according to the present invention, compared to an existing MTD, can transmit various types of biologically active molecule from inside the body and inside a test tube more effectively, and thus can be effectively used in a method to genetically alter a biologically active molecule so as to have cell permeability or in a method to transport a biologically active molecule into a cell, or the like. Additionally, the improved MTD can be very useful in development of new drugs and incrementally modified drugs as uses of the improved MTD are possible in drug delivery systems, recombinant protein vaccines or DNA/RNA therapeutic agents, gene or protein therapies, and pharmacologically or medically useful protein production or medical, pharmacological and pharmaceutical compositions.
申请公布号 US2014329737(A1) 申请公布日期 2014.11.06
申请号 US201214360317 申请日期 2012.11.23
申请人 Procell Therapeutics Inc. 发明人 Shin Ki Deok;Lee Kang Jin;Lim Sunny;Lee Byung Kyu;Kim Jong Rae
分类号 A61K47/48;A61Q19/08;C07K7/08;A61K8/64;C07K7/06;C12N15/113 主分类号 A61K47/48
代理机构 代理人
主权项 1. A peptide represented by Formula 1: A1-A2-MTD  [Formula 1] where A1 is methionine (M, Met), A2 is an amino acid selected from the group consisting of arginine (R, Arg), histidine (H, His) and lysine (K, Lys), and a MTD has an amino acid sequence selected from the group consisting of SEQ. ID. NOs: 1 to 7.
地址 Seoul KR